LEO Pharma and the Parker Institute Partner to Advance Skin Disease Research14.4.2025 10:00:00 CEST | LEO PharmaPressemeddelelse

LEO Pharma and the Parker Institute have entered a 3-year partnership with the objective to advance dermatology research. The collaboration will leverage the Parker Institute’s expertise in trial design, artificial intelligence, and SingleCell RNA sequencing and LEO Pharma’s global leadership in serving 90 million patients annually in medical dermatology to enhance understanding and treatment of skin diseases. This initiative reinforces LEO Pharma's commitment to unlock external innovation and drive standard of care improvement. Ballerup, Denmark, 14 April 2025 – LEO Pharma and the Parker Institute at Copenhagen University Hospital have formed an academic partnership to advance research and innovation in medical dermatology. This collaboration aims to produce high-quality research that enhances disease understanding and benefits patients. Furthermore, it aims to discover molecules that could potentially be integrated into broader pharmaceutical research and development efforts. “We are
VELUX FONDEN

Udvikling af juridiske kompetencer inden for bæredygtighed på tværs af Danmark14.4.2025 09:02:36 CEST | VELUX FONDENPressemeddelelse

Danmarks juridiske uddannelses- og forskningsmiljøer er netop gået sammen i et 5-årigt initiativ for at udvikle ny viden og kapacitetsopbygning inden for bæredygtighed. Gennem forskning og uddannelse inden for jura vil initiativet JURiB –’Juridiske Kompetencer inden for bæredygtighed’ – understøtte den grønne omstilling og udviklingen af et mere bæredygtigt samfund. VELUX FONDEN støtter initiativet, der skydes i gang med tre konkrete projekter, hvor bæredygtighed undersøges ud fra et virksomhedsperspektiv, et offentligretligt perspektiv og et internationalt perspektiv.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sidste
  • >>
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye